Strong leadership marred by post-merger confusion - Research Associate bei SpringWorks Therapeutics: Mitarbeiterbewertung

4,0
15. Apr. 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Innovative, robust leadership, community values

Kontras

Post merger confusion led to more problems in daily workflows

Mehr Bewertungen zu SpringWorks Therapeutics entdecken

5,0
1. Feb. 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

The culture- hype is real. Hands down, best culture I’ve ever worked in. Lets hope EMDS/ Merck KGaA doesn’t ruin it.

Kontras

The acquisition has been tough. Feels like we’ve joined a sinking ship. A lot of meetings, but real work doesn’t get done.

5,0
23. Juli 2025
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Remote, independent work; dedicated coworkers

Kontras

Resources as expected for midsize (capabilities/amenities of large pharma are not available)

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle